List of Contents

Plexaa Introduces BLOOM43, Advancing Breast Surgery Solutions in the U.S.


Published: 16 Oct 2025

Author: Precedence Research

Share : linkedin twitter facebook

The groundbreaking MedTech company, Plexāā, focused on enhancing surgical outcomes by introducing innovative devices and digital capabilities. They have officially announced the launch of their BLOOM43 platform in the U.S., a novel preconditioning medical technology that helps prepare patients for breast surgery. BLOOM43 system, a wearable device and a mobile application, is a significant step towards individual preparation for surgery and empowering patients. The device involves an advanced procedure known as Supraphysiological Preconditioning. This is a clinically-proven practice to increase skin strength and promote better wound healing, ultimately decreasing post-operation complications.

Plexaas

The BLOOM43 device targets patients, have breast reconstruction surgery, augmentation, or reduction surgery. The platform is integrated with the BLOOM43 companion application that gives personalized instructions on nutrition, hydration, and physical prehabilitation (Prehab). That makes patients surgery-ready holistically, both physically and psychologically. Through digital assistance and wearable accuracy medicine, Plexāā has transformed the manner in which a patient experiences their pre-operative process.

The BLOOM43 platform is also an innovation that will move surgical teams forward. A patient should be better informed and specifically physiologically optimized to reach the operating room, allowing surgeons to operate more confidently and enabling a smoother post-operative recovery with minimal complications. The U.S. is already receiving interest from early adopter hospitals and surgical centers due to its ability to standardize pre-surgical care and enhance patient satisfaction metrics. Plexāā will grow the BLOOM43 platform into other markets and will research the opportunities of the platform in other medical specialties. Furthermore, within the expanded scope of Plexāā's mission, the company envisions a time when digital prehabilitation and wearable devices will be standard in the surgical preparation process.

Executive’s Statement:

Dr. Saahil Mehta, CEO and Founder of Plexāā:

“Patients have always asked what they can do to prepare themselves for surgery. For years, we had few answers beyond general advice. BLOOM43 changes that. It’s not just a device; it’s a way to restore patient confidence, reduce risks, and put control back into the hands of those preparing for life-changing procedures. We’re proud to introduce a product that combines science, compassion, and innovation to make surgery safer and recovery smoother truly.”

Latest News